August 26, 2016 1:49 PM ET

Healthcare Equipment and Supplies

Company Overview of Delcath Systems, Inc.

Executive Profile

Roger G. Stoll Ph.D.

Chairman of the Board, Delcath Systems, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 9 different industries.

See Board Relationships
73$356,743
As of Fiscal Year 2015

Background

Dr. Roger G. Stoll, Ph.D. co-founded MassHealth Ventures LLP and serves as its Partner. Dr. Stoll served as an Executive Officer of Datex-Ohmeda. He served as President and Chief Executive Officer of Cortex Pharmaceuticals Inc., from August 13, 2002 to August 13, 2008. He served as an Executive Vice President of Fresenius Medical Care AG & Co. KGaA (formerly, Fresenius Medical Care Holdings Inc.) until January 31, 2001. From 1998 to January 2001, he served as an Executive ...

Corporate Headquarters

1301 Avenue of the Americas
New York, New York 10019

United States

Phone: 212-489-2100
Fax: 212-489-2102

Board Members Memberships

Director
2008-Present
Chairman of the Board
2008-Present
Independent Director, Chairman of Nominating & Governance Committee, Member of Audit & Risk Management Committee, Member of Strategic Advisory Committee and Member of Compensation Committee

Education

Post-Doctoral Training
University of Michigan
PhD
University of Connecticut
BS
Ferris State University

Other Affiliations

Annual Compensation

Salary$90,000
Total Annual Compensation$90,000

Stocks Options

Restricted Stock Awards$68,425
All Other Compensation$101,714
Exercisable Options$79,687
Unexercisable Options$42,500
Total Number of Options$122,187

Total Compensation

Total Annual Cash Compensation$208,714
Total Short Term Compensation$90,000
Other Long Term Compensation$170,139
Total Calculated Compensation$356,743
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$919.8K
Ali Fattaey Ph.D.Chief Executive Officer, President and Director
Curis, Inc.
$515.0K
Kevin T. Conroy Chairman of The Board, Chief Executive Officer and President
Exact Sciences Corporation
$852.7K
Gilman E. Wong Chief Executive Officer, Managing Director and Executive Director
Sirtex Medical Limited
$1.2M
James C. Clemmer Chief Executive Officer, President and Director
AngioDynamics Inc.
--
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Delcath Systems, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.